KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 96 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $79,755 | +5.2% | 10,147 | -9.5% | 0.00% | – |
| Q4 2022 | $75,834 | -57.4% | 11,218 | +9.7% | 0.00% | – |
| Q3 2021 | $178,000 | -95.2% | 10,222 | -93.4% | 0.00% | -100.0% |
| Q2 2021 | $3,734,000 | +4398.8% | 155,840 | +1331.8% | 0.00% | – |
| Q1 2020 | $83,000 | -36.2% | 10,884 | -3.3% | 0.00% | – |
| Q3 2019 | $130,000 | -97.7% | 11,257 | -95.6% | 0.00% | -100.0% |
| Q2 2019 | $5,729,000 | -36.2% | 258,673 | -17.6% | 0.00% | -66.7% |
| Q1 2019 | $8,980,000 | +64.4% | 313,791 | +13.5% | 0.00% | +50.0% |
| Q4 2018 | $5,461,000 | – | 276,523 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 589,270 | $8,686,000 | 5.61% |
| GREAT POINT PARTNERS LLC | 874,197 | $12,886,000 | 3.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 383,233 | $10,805,000 | 2.44% |
| Frazier Life Sciences Management, L.P. | 1,572,192 | $23,174,000 | 1.98% |
| TANG CAPITAL MANAGEMENT LLC | 648,269 | $9,555,000 | 1.91% |
| Deep Track Capital, LP | 1,729,757 | $25,497,000 | 1.64% |
| Vivo Capital, LLC | 1,533,559 | $22,605,000 | 1.56% |
| Monashee Investment Management LLC | 264,111 | $3,893,000 | 1.13% |
| COMMODORE CAPITAL LP | 312,553 | $4,607,000 | 1.03% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,746,300 | $25,740,000 | 0.79% |